SCHEMBL12217749

SCHEMBL12217749

Cc1cc(C(=O)N2CCN(CCO)CC2)ccc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.58
▸ POLB P06746 2/20 0.58
▸ HTT P42858 1/20 0.50
▸ AKR1C3 P42330 1/20 0.48
▸ NAMPT P43490 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HSP90AA1 P07900 1/20 0.46
▸ HSP90AB1 P08238 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ PDE3B Q13370 1/20 0.45
▸ PDE3A Q14432 1/20 0.45
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ DUSP3 P51452 1/20 0.44
▸ PTPN5 P54829 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12217604 0.86 ALDH1A1 (0.51) ALDH1A1POLBHSP90AA1HSP90AB1TSHR
SCHEMBL2378904 0.85 ALDH1A1 (0.56) ALDH1A1POLBHTTAKR1C3NAMPT
SCHEMBL12217821 0.84 KMT2A (0.60) ALDH1A1POLBMAPTHSP90AA1HSP90AB1
SCHEMBL10211716 0.81 ALDH1A1 (0.69) ALDH1A1POLBAKR1C3NAMPTKDM4E
SCHEMBL12217587 0.81 HPGD (0.64) ALDH1A1POLBHTTTSHRTP53
SCHEMBL12217590 0.81 HPGD (0.59) ALDH1A1POLBHTTHSP90AA1HSP90AB1
SCHEMBL10242018 0.79 HPGD (0.65) ALDH1A1POLBHTTTSHRTP53
SCHEMBL12286133 0.79 HPGD (0.64) ALDH1A1POLBHTTAKR1C3KDM4E
SCHEMBL12218522 0.79 KMT2A (0.61) ALDH1A1POLBTSHRTP53HPGD
SCHEMBL12217764 0.78 ALDH1A1 (0.56) ALDH1A1HTTAKR1C3HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039638-B2 Inhibitors of HIV replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-18 — — US disclosed
US-8039638-B2 Inhibitors of HIV replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-18 — — US disclosed
US-20100069353-A1 INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-03-18 — — US disclosed
US-20100069353-A1 INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-03-18 — — US disclosed
WO-2008067644-A1 INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-06-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069353-A1 INHIBITORS OF HIV REPLICATION RTF2, REV1, CCNT1 ALDH1A1 3455/4885POLB 89/4885HTT 3847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback